Campos L, de Oliveira F, Antunes A, Duarte J
Radiol Bras. 2024; 57:e20240025.
PMID: 39290827
PMC: 11406976.
DOI: 10.1590/0100-3984.2024.0025.
Tang C, Chen L, Xu Y, Huang L, Zeng Z
Front Neurol. 2024; 15:1439598.
PMID: 39131044
PMC: 11310134.
DOI: 10.3389/fneur.2024.1439598.
Rejimon A, Ramesh K, Trivedi A, Huang V, Schreibmann E, Weinberg B
Tomography. 2024; 10(3):428-443.
PMID: 38535775
PMC: 10975697.
DOI: 10.3390/tomography10030033.
Parmar V, Haubold J, Salhofer L, Meetschen M, Wrede K, Glas M
Neurooncol Adv. 2024; 6(1):vdae022.
PMID: 38516329
PMC: 10956963.
DOI: 10.1093/noajnl/vdae022.
He L, Zhang H, Li T, Yang J, Zhou Y, Wang J
Neurooncol Adv. 2024; 6(1):vdae013.
PMID: 38405203
PMC: 10894653.
DOI: 10.1093/noajnl/vdae013.
Utility of Diffusion Tensor Imaging in Assessing Corticospinal Tracts for the Management of Brain Tumors: A Cross-Sectional Observational Study.
Karmakar D, Badhe P, Mhatre P, Shrivastava S, Sultan M, Shankar G
Cureus. 2023; 15(10):e47811.
PMID: 38021806
PMC: 10679788.
DOI: 10.7759/cureus.47811.
Preclinical and Clinical Use of Indigenously Developed Tc-Diethylenetriaminepentaacetic Acid-Bis-Methionine: l-Type Amino Acid Transporter 1-Targeted Single Photon Emission Computed Tomography Radiotracer for Glioma Management.
Hazari P, Yadav S, Kumar P, Dhingra V, Rani N, Kumar R
ACS Pharmacol Transl Sci. 2023; 6(9):1233-1247.
PMID: 37705592
PMC: 10496141.
DOI: 10.1021/acsptsci.3c00091.
Characterization and clinical implications of different malignant transformation patterns in diffuse low-grade gliomas.
Jiang H, Zhu Q, Wang X, Li M, Shen S, Yang C
Cancer Sci. 2023; 114(9):3708-3718.
PMID: 37332121
PMC: 10475770.
DOI: 10.1111/cas.15889.
Delineation of Grade II and III Gliomas Investigated by 7T MRI: An Inter-Observer Pilot Study.
Prener M, Opheim G, Simonsen H, Engelmann C, Ziebell M, Carlsen J
Diagnostics (Basel). 2023; 13(8).
PMID: 37189466
PMC: 10137409.
DOI: 10.3390/diagnostics13081365.
Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response.
Vladimirov N, Perlman O
Int J Mol Sci. 2023; 24(4).
PMID: 36834563
PMC: 9959624.
DOI: 10.3390/ijms24043151.
Therapy Defining at Initial Diagnosis of Primary Brain Tumor-The Role of F-FET PET/CT and MRI.
Nagy D, Fedorcsak I, Bago A, Gati G, Martos J, Szabo P
Biomedicines. 2023; 11(1).
PMID: 36672636
PMC: 9855996.
DOI: 10.3390/biomedicines11010128.
Three-dimensional arterial spin labeling-guided dose painting radiotherapy for non-enhancing low-grade gliomas.
Zhu Z, Gong G, Wang L, Su Y, Lu J, Yin Y
Jpn J Radiol. 2022; 41(3):335-346.
PMID: 36342645
PMC: 9974719.
DOI: 10.1007/s11604-022-01357-z.
Bibliometric and visualized analysis of the application of nanotechnology in glioma.
Du X, Chen C, Yang L, Cui Y, Tan B
Front Pharmacol. 2022; 13:995512.
PMID: 36188579
PMC: 9520472.
DOI: 10.3389/fphar.2022.995512.
3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.
Hou H, Chen W, Diao Y, Wang Y, Zhang L, Wang L
Mol Imaging Biol. 2022; 25(2):343-352.
PMID: 35962302
DOI: 10.1007/s11307-022-01762-w.
Three-Dimensional Arterial Spin Labeling-Guided Sub-Volume Segmentation of Radiotherapy in Adult Non-Enhancing Low-Grade Gliomas.
Zhu Z, Gong G, Wang L, Su Y, Lu J, Yin Y
Front Oncol. 2022; 12:914507.
PMID: 35860561
PMC: 9291222.
DOI: 10.3389/fonc.2022.914507.
3D Amide Proton Transfer Weighted Brain Tumor Imaging With Compressed SENSE: Effects of Different Acceleration Factors.
Zhang N, Zhang H, Gao B, Miao Y, Liu A, Song Q
Front Neurosci. 2022; 16:876587.
PMID: 35692419
PMC: 9178274.
DOI: 10.3389/fnins.2022.876587.
The Use of F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds-A Narrative Review.
van de Weijer T, Broen M, Moonen R, Hoeben A, Anten M, Hovinga K
Diagnostics (Basel). 2022; 12(5).
PMID: 35626357
PMC: 9140561.
DOI: 10.3390/diagnostics12051202.
Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters.
Pruis I, Koene S, Van der Voort S, Incekara F, Vincent A, van den Bent M
Neurooncol Adv. 2022; 4(1):vdac023.
PMID: 35300151
PMC: 8923005.
DOI: 10.1093/noajnl/vdac023.
Advanced Imaging Techniques for Newly Diagnosed and Recurrent Gliomas.
Carrete L, Young J, Cha S
Front Neurosci. 2022; 16:787755.
PMID: 35281485
PMC: 8904563.
DOI: 10.3389/fnins.2022.787755.
Molecular Imaging of Brain Tumors and Drug Delivery Using CEST MRI: Promises and Challenges.
Huang J, Chen Z, Park S, Lai J, Chan K
Pharmaceutics. 2022; 14(2).
PMID: 35214183
PMC: 8880023.
DOI: 10.3390/pharmaceutics14020451.